| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/12/2009 | CN101503736A Use of retinoic acid induced gene I, signal pathway mediated by coding protein thereof |
| 08/12/2009 | CN101503685A Anticancer recombinant adenovirus with tumour cell miR-221/222 as drug target, construction method and use |
| 08/12/2009 | CN101503677A Recombinant adenovirus of Survivin promoter regulated human NIS gene, construction method and use |
| 08/12/2009 | CN101503453A Nucleic acid molecule CRYL1SI3 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503452A Nucleic acid molecule CRYL1SI32 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503451A Nucleic acid molecule CXSI2 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503450A Nucleic acid molecule CXSI3 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503449A Nucleic acid molecule CXSI32 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503448A Nucleic acid molecule CXSI22 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503447A Nucleic acid molecule CXSI2 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503446A Nucleic acid molecule CXSI1 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503445A Nucleic acid molecule SI-CYPJ-32 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503444A Nucleic acid molecule SI-CYPJ-3 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503443A Nucleic acid molecule SI-CYPJ-22 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503442A Nucleic acid molecule SI-CYPJ-2 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503441A Nucleic acid molecule SI-CYPJ-1 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503440A Nucleic acid molecule SI-CYPJ-12 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503439A Nucleic acid molecule SI-CYPJ-52 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503438A Nucleic acid molecule SI-CYPJ-5 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503437A Nucleic acid molecule SI-CYPJ-4 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503436A Nucleic acid molecule SI-CYPJ-42 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101502659A Novel use of Kruppel-like transcription factor 4 |
| 08/12/2009 | CN101502658A FLIP protein and novel use of encoding gene thereof |
| 08/12/2009 | CN101502642A Use of hepatitis B virus x protein and encoding gene thereof in preparing medicament for treating cancer of liver |
| 08/12/2009 | CN100526331C CTL epitopes from EBV |
| 08/11/2009 | US7572906 for drug screening treatments for human immunodeficiency virus (HIV), cancer; gene therapy; long terminal repeat sequences; genetic engineering |
| 08/11/2009 | US7572899 Compositions and methods for increasing bone mineralization |
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572768 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 08/11/2009 | US7572633 Use of the adenoviral E2 late promoter |
| 08/11/2009 | US7572628 Eukaryotic layered vector initiation systems |
| 08/11/2009 | US7572619 Using immortalized trangenic cell to express antihemophilic factor and blood coagulation factor IX for treatment of blood disorders |
| 08/11/2009 | US7572580 Promoter variants of the alpha-7 nicotinic acetylcholine receptor |
| 08/11/2009 | US7572446 Antagonists of HMG1 for treating inflammatory conditions |
| 08/11/2009 | US7572438 Mutant having uracil phosphoribosyl transferase activity |
| 08/11/2009 | CA2408535C Compositions comprising dendrimer complexes |
| 08/11/2009 | CA2348732C Human h37 proteins and cdnas encoding the same |
| 08/11/2009 | CA2328133C Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 08/11/2009 | CA2289283C Metastasis models using green fluorescent protein (gfp) as a marker |
| 08/06/2009 | WO2009097530A2 Peptides that target dorsal root ganglion neurons |
| 08/06/2009 | WO2009097119A2 Identification of cd8+ t cells that are cd161hi and/or il18r(alpha)hi and have rapid drug efflux capacity |
| 08/06/2009 | WO2009097077A2 Wound healing compositions and treatments |
| 08/06/2009 | WO2009096612A1 Regulation of neutrotransmittter release through anion channels |
| 08/06/2009 | WO2009096425A1 Neovascularization-promoting factor |
| 08/06/2009 | WO2009095887A1 Cationic sirnas, synthesis and use for interfering rna |
| 08/06/2009 | WO2009095796A2 Tapasin augmentation for enhanced immune response |
| 08/06/2009 | WO2009061130A3 Cell permeable runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same |
| 08/06/2009 | WO2009054996A9 Systems and methods for viral therapy |
| 08/06/2009 | WO2008086484A8 Compositions and methods for treating cardiovascular disease |
| 08/06/2009 | WO2008045548A3 Codon optimized cftr |
| 08/06/2009 | US20090198047 2'-Modified Oligonucleotides |
| 08/06/2009 | US20090198043 Feline il-18 proteins |
| 08/06/2009 | US20090197336 Suppression of polymorphic alleles |
| 08/06/2009 | US20090197256 Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems |
| 08/06/2009 | US20090196888 Nucleic acids encoding recombinant 56 and 82 kDa antigents from gametocytes of Eimeria maxima and their uses |
| 08/06/2009 | US20090196854 Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery |
| 08/06/2009 | CA2713338A1 Recombinant virus production using mammalian cells in suspension |
| 08/06/2009 | CA2713075A1 Cationic sirnas, synthesis and use for interfering rna |
| 08/06/2009 | CA2712964A1 Tapasin augmentation for enhanced immune response |
| 08/06/2009 | CA2711635A1 Wound healing compositions and treatments |
| 08/05/2009 | EP2085478A1 A long QT syndrome gene which encodes KVLQT1 and its association with minK |
| 08/05/2009 | EP2085090A2 Inhibitors of DNA immunostimulatory sequence activity |
| 08/05/2009 | EP2084297A2 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof |
| 08/05/2009 | EP1987148A4 De-differentiation of astrocytes into neural stem cell using bmi-1 |
| 08/05/2009 | EP1651050A4 Acellular tissue matrices made from galactose alpha-1,3-galactose -deficient tissue |
| 08/05/2009 | EP1499735B1 Optimization of transgene expression in mammalian cells |
| 08/05/2009 | EP1317561B1 Modulation of homologous recombination with single stranded dna binding proteins |
| 08/05/2009 | EP1286703B1 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 08/05/2009 | EP1257579B1 Novel human g protein coupled receptor proteins and polynucleotides encoding the same |
| 08/05/2009 | EP1246913B1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 08/05/2009 | EP1023005B1 Stent coated with dna |
| 08/05/2009 | EP0938553B1 Dna encoding dp-75 and a process for its use |
| 08/05/2009 | CN101501221A Controlling osteogenesis by inhibition of osteogenic suppressors |
| 08/05/2009 | CN101500616A Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| 08/05/2009 | CN101500604A Plasmids with immunological action |
| 08/05/2009 | CN101497922A Use of PNMA5 gene |
| 08/05/2009 | CN101497891A Novel recombinant viral vector and use thereof |
| 08/05/2009 | CN101497882A Anti- mycobacterium tuberculosis infection small molecule nucleotide DNA aptamer and preparation thereof |
| 08/05/2009 | CN101497881A Vaccine reading frame crosslinking with human molecule adjuvant hC3d3 same sense mutant |
| 08/05/2009 | CN101497876A Recombinant adenovirus for expressing targetedly proliferating recombinant adenovirus for expressing proapoptosis gene and use thereof |
| 08/05/2009 | CN101497653A Small peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 08/05/2009 | CN101497652A Peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 08/05/2009 | CN100523215C RNA interference mediating small RNA molecules |
| 08/05/2009 | CN100523187C Modified chimeric polyeptides with improved pharmacokinetic properties |
| 08/05/2009 | CN100522997C Method and composition for treating cardiovascular diseases by employing neuroregulation protein |
| 08/05/2009 | CN100522250C N type non-viral vector and pharmaceutical composition containing same |
| 08/04/2009 | US7569720 Compounds |
| 08/04/2009 | US7569684 siRNA targeting gremlin |
| 08/04/2009 | US7569682 nucleic acid sequences encoding a 30 kD Brachyspira hyodysenteriae lipoprotein; host cell; new locus comprising four genes has now surprisingly been found; swine dysentery |
| 08/04/2009 | US7569668 Method to control tumor progression and invasiveness |
| 08/04/2009 | US7569666 Polypeptides associated with activatory receptors and their biological applications |
| 08/04/2009 | US7569558 Chromium benfotiamine picolinate, copper adenosine triphosphate gluconate or vanadium pyridoxal-5-phosphate oxoglycinate; modulation of metalloenzymes; antiinflammatory, skin whitening, wrinkle reduction, skin aging control, cellular antioxidant, acne control, hair growth modulation |
| 08/04/2009 | US7569554 Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents |
| 08/04/2009 | US7569552 Attenuated Salmonella typhimurium bacteria comprising a plasmid encoding a polyubiquinated Fra-1 (Fos-related antigen-1) protein and a plasmid encoding Interleukin-18 (IL-18); cancer vaccines |
| 08/04/2009 | US7569551 Administering composition effective to inhibit expression of testosterone-repressed prostate message-2 gene in renal cell cancer |
| 08/04/2009 | US7569544 drug biological conjugates used in the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers |
| 08/04/2009 | US7569538 Vaccines against cancer of the upper respiratory tract or anogenital carcinomas, such as cervical cancer, using fragments of the cyclin-dependent kinase inhibitor P16 protein |
| 08/04/2009 | US7569387 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 08/04/2009 | US7569383 Chimeric flavivirus vectors |
| 08/04/2009 | US7569352 Method for identifying modulators of the dioxin/aryl hydrocarbon receptor (AHR) |